Protective Role of Lotus Leaf Polysaccharides in Mice with
Ulcerative Colitis
Wenying Bi 1,#, Jitao Sun 2, #,
Ying Zhang 1, #, Zhaojing Luo 4, #, Xue Zhang
6, Na Xia 1, Baoying Chen 1, Yanyun
Che 7, 8, Sandie Siew Shean Choong 5, Liwei
Guo 4, 8, Weijie Qu 1, Xiaonan Yang 9,
Yi Wu 3, 8, *, Xin Wu 1, * and Qiu Zhong
3, *
1College
of Veterinary Medicine, Yunnan Agricultural University, Kunming,
China; 2College of Basic Medicine, Inner Mongolia Medical
University, Hohhot, China; 3Guangxi Key Laboratory of
Animal Breeding, Disease Control and Prevention, College of Animal
Science and Veterinary Medicine, Guangxi University, Nanning,
Guangxi, China; 4School of Animal Science, Yangtze
University, Jingzhou, China; 5Faculty of Veterinary
Medicine, Universiti Malaysia Kelantan, Kota Bharu, Malaysia; 6College
of Animal Science and Technology, Yunnan Agricultural University,
Kunming, China; 7China Engineering research center for
homology of medicine and food beverage of Yunnan Province, College
of Pharmaceutical Science, Yunnan University of Chinese Medicine,
Kunming, China; 8Yunnan Characteristic Plant Extraction
Laboratory, Kunming, China; 9National Engineering
Research Center for Southwest Endangered Medicinal Resources
Development, Guangxi Botanical Garden of Medicinal Plants, Nanning
530023, China.
The incidence of ulcerative colitis (UC) is increasing worldwide, and the
development of drugs to protect against UC is imminent. Lotus leaf
polysaccharides (LLP) have anti-inflammatory effects. It is necessary to
investigate whether they are effective against ulcerative colitis. This study
aimed to evaluate the anti-UC effects. RAW264.7 LPS-induced inflammation model
and a Dextran Sulfate Sodium Salt (DSS)-induced ulcerative colitis model in mice
were used to assess the anti-UC effects of LLP. LLP can improve the antioxidant
activity and anti-inflammatory effects in the LPS-induced RAW264.7 inflammation
model. In the DSS model, LLP significantly improved pathological features,
including increased body weight, colon length, reduced bloody stool, and
effective protection of the intestinal structure, as well as inhibition of
inflammatory factor production. LLP also increased the goblet cell numbers (as
determined by PAS staining), significantly enhanced the tight junction (TJ)
protein (Claudin-1, Occludin, ZO-1) expression (P<0.05), which helps maintain
the integrity of the intestinal barrier, and inhibited the TLR4-MAPK/NF-κB
signaling pathway. Furthermore, analysis of colon microbiota in DSS-treated mice
revealed that LLP restored the bacterial structure damaged by DSS, improved the
composition of intestinal flora, and increased the ratio of the Firmicutes/Bacteroidetes
ratio. Additionally, metabolite analysis showed that LLP altered metabolite
profiles and up-regulated pathways involving arginine, ornithine, and lysine,
which may be associated with LLP’s inhibition of UC. Overall, LLP exerts anti-UC
effects by modulating gut microbiota and metabolism, enhancing antioxidant
capacity, and strengthening the integrity of colonic tight junctions.
To Cite This Article:
Bi W, Sun J, Zhang Y, Luo Z, Zhang Z, Xia
N, Chen B, Che Y, Choong SSS, Guo L, Qu W, Yang X, Wu Y, Wu X and Zhong Q,
2025. Protective role of lotus leaf
polysaccharides in mice with ulcerative colitis. Pak Vet J.
http://dx.doi.org/10.29261/pakvetj/2025.323